Biofrontera Other Current Liab from 2010 to 2024

BFRIW Stock  USD 0.06  0  1.69%   
Biofrontera Warrants Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities is likely to outpace its year average in 2024. During the period from 2010 to 2024, Biofrontera Warrants Other Current Liabilities regression line of quarterly data had mean square error of 5.9 T and geometric mean of  8,964,157. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
3.8 M
Current Value
6.3 M
Quarterly Volatility
2.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 90.6 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.85. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Biofrontera Warrants over the last few years. It is Biofrontera Warrants' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Biofrontera Other Current Liab Regression Statistics

Arithmetic Mean9,586,928
Geometric Mean8,964,157
Coefficient Of Variation29.43
Mean Deviation2,104,115
Median10,921,000
Standard Deviation2,820,981
Sample Variance8T
Range8.8M
R-Value(0.56)
Mean Square Error5.9T
R-Squared0.32
Significance0.03
Slope(355,184)
Total Sum of Squares111.4T

Biofrontera Other Current Liab History

20246.3 M
20233.8 M
202211.7 M
20219.9 M
20202.9 M

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities3.8 M6.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.